The Company is now subject to the reporting requirements of the Securities Exchange Act of 1934
SACRAMENTO, CA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Boon Industries, Inc. (OTC PINK: BNOW) ("Boon" or the "Company"), an innovative bioscience company delivering solutions that benefit people and the planet, is pleased to announce today that its Form 10 Registration Statement filed with the U.S. Securities and Exchange Commission (the "SEC") became effective on February 14, 2022. As a result, the Company is now subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, and is required to file annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K.
The Form 10 filing affords investors detailed information regarding the Company and its operations, including audited financial statements. This transparency should assist the investing public in making more informed investment decisions as they pertain to the Company's equity. The Form 10 can be reviewed in its entirety at www.sec.gov under the name of Boon Industries, Inc.
"We believe that the effectiveness of our Form 10 registration statement is a watershed event for Boon and its shareholders," stated Justin Gonzalez, Chairman & CEO, Boon Industries. "We sincerely appreciate the patience of our partners and investors as we move this company into an important new phase of expanded production and with the sunlight of transparency to record and celebrate our successes.
"Overall, this progress aligns with Boon's commitment to a new phase for the Company wherein we are pursuing new market opportunities and transparency simultaneously," added Gonzalez.
About Boon Industries
Boon Industries, Inc. (OTC:BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon's product offering is DiOx+™, a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind DiOx+ make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. DiOx+ helps protect agricultural crops from disease, is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon's CEO Justin Gonzalez. DiOx+ delivers on Boon's promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon's manufacturing facility and corporate headquarters in Grass Valley, California.
Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:
LinkedIn:
Twitter:
The Company's most current Investor Presentation is available at the following link:
Company Contact
Boon Industries, Inc.
Investor Relations & Financial Media
Integrity Media Inc.
team@integritymedia.com
Toll Free: (888) 216-3595
The Company is now subject to the reporting requirements of the Securities Exchange Act of 1934
SACRAMENTO, CA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Boon Industries, Inc. (OTC PINK: BNOW) ("Boon" or the "Company"), an innovative bioscience company delivering solutions that benefit people and the planet, is pleased to announce today that its Form 10 Registration Statement filed with the U.S. Securities and Exchange Commission (the "SEC") became effective on February 14, 2022. As a result, the Company is now subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, and is required to file annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K.
加利福尼亚州萨克拉门托，2022年2月24日(环球通讯社)NewMediaWire--Boon Industries，Inc.(场外交易PINK：BNOW)博恩公司(“Boon”或“公司”)，一家提供造福人类和地球解决方案的创新型生物科学公司，今天高兴地宣布，其提交给美国证券交易委员会(“美国证券交易委员会”)的Form 10注册声明于2022年2月14日生效。因此，公司现在必须遵守修订后的1934年证券交易法的报告要求，并必须向美国证券交易委员会提交年度报告(Form 10-K)、季度报告(Form 10-Q)和定期报告(Form 8-K)。
The Form 10 filing affords investors detailed information regarding the Company and its operations, including audited financial statements. This transparency should assist the investing public in making more informed investment decisions as they pertain to the Company's equity. The Form 10 can be reviewed in its entirety at www.sec.gov under the name of Boon Industries, Inc.
Form 10文件向投资者提供了有关该公司及其运营的详细信息，包括经审计的财务报表。这种透明度应该有助于投资公众做出更明智的投资决策，因为这些决策与公司的股权有关。表格10可在www.sec.gov上以Boon Industries，Inc.的名义进行完整审查。
"We believe that the effectiveness of our Form 10 registration statement is a watershed event for Boon and its shareholders," stated Justin Gonzalez, Chairman & CEO, Boon Industries. "We sincerely appreciate the patience of our partners and investors as we move this company into an important new phase of expanded production and with the sunlight of transparency to record and celebrate our successes.
布恩工业公司董事长兼首席执行官贾斯汀·冈萨雷斯说：“我们相信，我们的Form 10注册声明的有效性对布恩公司及其股东来说是一个分水岭事件。”我们衷心感谢我们的合作伙伴和投资者在我们将公司带入扩大生产的重要新阶段的过程中所表现出的耐心，并在透明的阳光下记录和庆祝我们的成功。
"Overall, this progress aligns with Boon's commitment to a new phase for the Company wherein we are pursuing new market opportunities and transparency simultaneously," added Gonzalez.
冈萨雷斯补充说：“总体而言，这一进展与Boon对公司新阶段的承诺相一致，在这个阶段，我们正在寻求新的市场机会和透明度。”
Boon Industries, Inc. (OTC:BNOW) is an innovative bioscience company delivering solutions that benefit people and the planet. At the core of Boon's product offering is DiOx+™, a chlorine dioxide disinfectant sterilizer. Chlorine dioxide has been approved by OSHA, FDA, EPA, and DOT. DiOx+ kills harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind DiOx+ make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. DiOx+ helps protect agricultural crops from disease, is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 12 years of chlorine dioxide usage in global markets driven by Boon's CEO Justin Gonzalez. DiOx+ delivers on Boon's promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon's manufacturing facility and corporate headquarters in Grass Valley, California.
Boon Industries，Inc.(场外交易代码：BNOW)是一家创新的生物科学公司，提供造福人类和地球的解决方案。布恩公司产品的核心是DIOX+™，这是一种二氧化氯消毒剂消毒器。二氧化氯已获得OSHA、FDA、EPA和DOT的批准。DIOX+可杀死有害病原体，而不会对使用者或环境产生危险的有毒影响。DIOX+背后的专利化学配方和工艺使其成为关键任务、高价值医疗设备杀菌以及实验室和医院环境中空气和表面消毒的理想选择。DIOX+有助于保护农作物免受疾病侵袭，用于水处理厂，并有助于降低仓储、配送中心和电子商务支持设施的运营成本。在将Diox+引入美国市场之前，Boon的首席执行官贾斯汀·冈萨雷斯(Justin Gonzalez)推动了二氧化氯在全球市场12年的使用。Diox+兑现了Boon的承诺，在不牺牲健康和安全的情况下提供最有效、最实惠的解决方案。Diox+是在布恩公司位于加利福尼亚州草谷的制造工厂和公司总部生产的。
Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as "believes", "anticipates", "expects", "estimates", "may", "could", "would", "will", or "plan". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
前瞻性陈述的避风港：本新闻稿包含非历史事实的前瞻性陈述。前瞻性陈述包括描述公司未来计划、目标或目标的估计和陈述，包括大意是公司或管理层预计会出现某种情况或结果的文字。前瞻性陈述可以用“相信”、“预期”、“预期”、“估计”、“可能”、“将”或“计划”等术语来识别。由于前瞻性陈述基于假设，涉及未来的事件和条件，因此它们本身就包含固有的风险和不确定因素。虽然这些陈述是基于公司目前掌握的信息，但公司不能保证实际结果符合管理层的期望。前瞻性信息涉及的风险、不确定性和其他因素可能导致实际事件、结果、业绩、前景和机会与此类前瞻性信息明示或暗示的情况大不相同。可能导致实际结果与这些前瞻性信息大不相同的因素包括但不限于总体经济和金融市场状况的变化。尽管公司认为在准备本新闻稿中的前瞻性信息时使用的假设和因素是合理的，但不应过度依赖这些信息，因为这些信息仅适用于本新闻稿发布之日，并且不能保证此类事件将在披露的时间框架内发生或根本不会发生。除法律要求外，公司没有任何更新或修改任何前瞻性信息的意图或义务，无论是由于新信息、未来事件或其他原因。
Please note that from time to time the Company may post new information at its website boonindustries.com, or via its current social media accounts below:
请注意，公司可能会不时在其网站上发布新信息Boonindustries.com，或通过其目前的社交媒体账户如下：
The Company's most current Investor Presentation is available at the following link:
Company Contact
Boon Industries, Inc.
公司联系人
Boon Industries，Inc.
Investor Relations & Financial Media
邮箱：team@Integritymedia.com
Toll Free: (888) 216-3595
